India Drug Firms Look Abroad For Trials, Government Tries To Trim Delays
This article was originally published in PharmAsia News
Executive Summary
India's Serum Institute faced more than a year's delay getting approval for a Phase III trial for a rotavirus vaccine, leading it to look elsewhere for clinical trials of other vaccines, its executive director said.